{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T21:44:45Z","timestamp":1777153485278,"version":"3.51.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.psychres.2020.112937","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T10:47:42Z","timestamp":1586429262000},"page":"112937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Symptom scores and medication treatment patterns in children with ADHD versus autism"],"prefix":"10.1016","volume":"288","author":[{"given":"Susan D.","family":"Mayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Waxmonsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Baweja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Mattison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Memon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Waschbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2020.112937_bib0001","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/1044546041649020","article-title":"Risperidone effects in the presence\/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ","volume":"14","author":"Aman","year":"2004","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0002","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/cap.2005.15.116","article-title":"Medication patterns in patients with autism: temporal, regional, and demographic influences","volume":"15","author":"Aman","year":"2005","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5812\/ijp.265","article-title":"Risperidone versus methylphenidate in treatment of preschool children with attention-deficit hyperactivity disorder","volume":"25","author":"Arabgol","year":"2015","journal-title":"Iranian J. Pediatr."},{"key":"10.1016\/j.psychres.2020.112937_bib0004","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1097\/01.chi.0000231976.28719.2a","article-title":"Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trials","volume":"45","author":"Arnold","year":"2006","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/cap.2014.0104","article-title":"Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response","volume":"25","author":"Arnold","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0006","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40272-015-0144-2","article-title":"Impact of attention-deficit hyperactivity disorder on school performance: what are the effects of medication?","volume":"17","author":"Baweja","year":"2015","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.psychres.2020.112937_bib0007","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/sleep\/32.6.731","article-title":"Sleep disordered breathing in children in a general population sample: prevalence and risk factors","volume":"32","author":"Bixler","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.psychres.2020.112937_bib0008","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10803-006-0125-y","article-title":"Psychopathology in children and adolescents with autism compared to young people with intellectual disability","volume":"36","author":"Brereton","year":"2006","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0009","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/pds.3897","article-title":"Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens","volume":"25","author":"Burcu","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.psychres.2020.112937_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10802-016-0166-4","article-title":"Behavioral profiles associated with objective sleep duration in young children with insomnia symptoms","volume":"45","author":"Calhoun","year":"2017","journal-title":"J. Abnorm. Child Psychol."},{"key":"10.1016\/j.psychres.2020.112937_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1753-2000-1-10","article-title":"A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit\/hyperactivity disorder","volume":"1","author":"Carlson","year":"2007","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"key":"10.1016\/j.psychres.2020.112937_bib0012","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s007870050083","article-title":"Autistic symptoms in children with attention deficit-hyperactivity disorder","volume":"8","author":"Clark","year":"1999","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0013","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.chi.0000246070.23695.06","article-title":"Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders","volume":"46","author":"Connolly","year":"2007","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0014","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/DBP.0b013e3181e121bd","article-title":"A review of attention-deficit\/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder","volume":"31","author":"Connor","year":"2010","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.psychres.2020.112937_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1542\/peds.2009-0634","article-title":"Biological and environmental predictors of behavioral sequelae in children born preterm","volume":"125","author":"Conrad","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.psychres.2020.112937_bib0016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1542\/peds.2012-0900D","article-title":"Use of psychotropic medication in children and adolescent with autism spectrum disorders","volume":"130","author":"Coury","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.psychres.2020.112937_bib0017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaac.2014.10.006","article-title":"Treatment of children with attention-deficit\/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA)","volume":"54","author":"de la Cruz","year":"2015","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1037\/1064-1297.9.2.163","article-title":"Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD","volume":"9","author":"Evans","year":"2001","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0019","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.chi.0000166986.30592.67","article-title":"Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation","volume":"44","author":"Filho","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0012162206000375","article-title":"Fine motor skills and effects of methylphenidate in children with attention-deficit-hyperactivity disorder and developmental coordination disorder","volume":"48","author":"Flapper","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.psychres.2020.112937_bib0021","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/cap.2011.0057","article-title":"Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit\/ hyperactivity disorder","volume":"21","author":"Frazier","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0022","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2190\/PM.38.2.c","article-title":"Comfort level of pediatricians and family medicine physicians diagnosing and treating child and adolescent psychiatric disorders","volume":"38","author":"Fremon","year":"2008","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.psychres.2020.112937_bib0023","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaac.2014.05.008","article-title":"Risperidone added to parent training and stimulant medication: effects on attention- deficit\/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression","volume":"53","author":"Gadow","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2014.09.017","article-title":"A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism","volume":"52","author":"Ghanizadeh","year":"1997","journal-title":"Pediatric. Neurol."},{"key":"10.1016\/j.psychres.2020.112937_bib0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archpsyc.1997.01830210105014","article-title":"Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms","volume":"54","author":"Gillberg","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0026","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/10634266020100020201","article-title":"Are students with ADHD more stressful to teach? Patterns of teacher stress in an elementary school sample","volume":"10","author":"Greene","year":"2002","journal-title":"J. Emot. Behav. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0027","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1005548619694","article-title":"Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder","volume":"30","author":"Handen","year":"2000","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0028","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/DBP.0b013e3181739b9d","article-title":"Guanfacine in children with autism and\/or intellectual disabilities","volume":"29","author":"Handen","year":"2008","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.psychres.2020.112937_bib0029","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/cap.2014.0026","article-title":"Atomoxetine in autism spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change","volume":"24","author":"Harfterkamp","year":"2014","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jaac.2012.04.011","article-title":"A randomized double-blind study of atomoxetine versus placebo for attention-deficit\/hyperactivity disorder symptoms in children with autism spectrum disorder","volume":"51","author":"Harfterkamp","year":"2012","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0031","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/0706743716689055","article-title":"ADHD treatment in primary care: demographic factors, medication trends, and treatment predictors","volume":"62","author":"Hauck","year":"2017","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0032","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00004714-199210000-00005","article-title":"Clonidine treatment of hyperactive and impulsive children with autistic disorder","volume":"12","author":"Jaselskis","year":"1992","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0033","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/1087054714543368","article-title":"Symptom profiles of ADHD in youth with high-functioning autism spectrum disorder: a comparative study in psychiatrically referred populations","volume":"21","author":"Joshi","year":"2017","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0034","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/002221948201500508","article-title":"The efficacy of stimulant drug treatment for hyperactivity: a meta-analysis","volume":"15","author":"Kavale","year":"1982","journal-title":"J. Learn. Disabil."},{"key":"10.1016\/j.psychres.2020.112937_bib0035","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior","volume":"66","author":"King","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0036","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/cap.2010.0064","article-title":"Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit\/hyperactivity disorder","volume":"21","author":"Kollins","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0037","series-title":"Advances in Behavioral Assessment of Children and Families","first-page":"57","article-title":"Assessing child behavior problems in a medical setting: development of the pediatric behavior scale","author":"Lindgren","year":"1987"},{"key":"10.1016\/j.psychres.2020.112937_bib0038","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/cap.2013.0119","article-title":"Aberrant behaviors and co-occurring conditions as predictors of psychotropic polypharmacy among children with autism spectrum disorders","volume":"25","author":"Logan","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0039","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10803-016-2946-7","article-title":"Psychotropic medication use among insured children with autism spectrum disorder","volume":"47","author":"Madden","year":"2017","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1542\/peds.2007-0984","article-title":"Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders","volume":"121","author":"Mandell","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.psychres.2020.112937_bib0041","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00004583-199907000-00024","article-title":"Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use","volume":"38","author":"Martin","year":"1999","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0042","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1087054710380188","article-title":"Relationship between learning disability, executive function, and psychopathology in children with ADHD","volume":"16","author":"Mattison","year":"2012","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0043","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00004583-199808000-00014","article-title":"Attention-deficit hyperactivity symptomatology after traumatic brain injury: a prospective study","volume":"37","author":"Max","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0044","series-title":"Checklist for Autism Spectrum Disorder","author":"Mayes","year":"2012"},{"key":"10.1016\/j.psychres.2020.112937_bib0045","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s10803-009-0812-6","volume":"39","author":"Mayes","year":"2009","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rasd.2011.08.001","article-title":"Explosive, oppositional, and aggressive behavior in children with autism compared to other clinical disorders and typical development","volume":"6","author":"Mayes","year":"2012","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0047","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.rasd.2011.05.009","article-title":"Autism and ADHD: overlapping and discriminating symptoms","volume":"6","author":"Mayes","year":"2012","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0048","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.rasd.2010.06.012","article-title":"Anxiety, depression, and irritability in children with autism relative to children with other neuropsychiatric disorders and typical development","volume":"5","author":"Mayes","year":"2011","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0049","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/1359104516678039","article-title":"Autism and reactive attachment\/disinhibited social engagement disorders: co-occurrence and differentiation","volume":"22","author":"Mayes","year":"2017","journal-title":"Clin. Child Psychol. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10882-018-9598-9","article-title":"Diagnostic, demographic, and neurocognitive predictors of dysgraphia in students with ADHD, autism, learning disabilities, and typical development","volume":"30","author":"Mayes","year":"2018","journal-title":"J. Dev. Phys. Disabil."},{"key":"10.1016\/j.psychres.2020.112937_bib0051","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1087054712448961","article-title":"Long-term temporal stability of measured inattention and impulsivity in typical and referred children","volume":"18","author":"Mayes","year":"2014","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0052","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1469-8749.1994.tb11811.x","article-title":"Methylphenidate and ADHD: influence of age, IQ, and neurodevelopmental status","volume":"36","author":"Mayes","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.psychres.2020.112937_bib0053","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.rasd.2015.07.003","article-title":"Disruptive mood dysregulation disorder (DMDD) symptoms in children with autism, ADHD, and neurotypical development and impact of co-occurring ODD, depression, and anxiety","volume":"18","author":"Mayes","year":"2015","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0054","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/cap.2015.0074","article-title":"Disruptive mood dysregulation disorder symptoms and association with oppositional defiant and other disorders in a general population child sample","volume":"26","author":"Mayes","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0055","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.psychres.2020.112937_bib0056","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/appi.ajp.162.6.1142","article-title":"Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology","volume":"162","author":"McDougle","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.108.5.e83","article-title":"Atomoxetine in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled, dose-response study","volume":"108","author":"Michelson","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.psychres.2020.112937_bib0058","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1542\/peds.2015-1502","article-title":"Timing of the diagnosis of attention-deficit\/hyperactivity disorder and autism spectrum disorder","volume":"136","author":"Miodovnik","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.psychres.2020.112937_bib0059","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","article-title":"14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder","volume":"56","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0060","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s10803-011-1178-0","article-title":"Brief report: excellent agreement between two brief autism scales (checklist for autism spectrum disorder and social responsiveness scale) completed independently by parents and the autism diagnostic interview-revised","volume":"41","author":"Murray","year":"2011","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0061","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/08830738060210060801","article-title":"Risperidone in children with autism: randomized, placebo-controlled, double-blind study","volume":"21","author":"Nagaraj","year":"2006","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.psychres.2020.112937_bib0062","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaac.2013.06.006","article-title":"Randomized, double-blind trial of guanfacine extended release in children with attention-deficit\/hyperactivity disorder: morning or evening administration","volume":"52","author":"Newcorn","year":"2013","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0063","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jpepsy\/25.8.545","article-title":"HIV-associated changes in adaptive, emotional, and behavioral functioning in children and adolescents with hemophilia: results from the hemophilia growth and development study","volume":"25","author":"Nichols","year":"2000","journal-title":"J. Pediatr. Psychol."},{"key":"10.1016\/j.psychres.2020.112937_bib0064","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/DBP.0b013e31815f24f7","article-title":"Stimulant medication treatment of target behaviors in children with autism: a population-based study","volume":"29","author":"Nickels","year":"2008","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.psychres.2020.112937_bib0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/cap.2006.17303","article-title":"Medication use among children with autism spectrum disorders","volume":"17","author":"Oswald","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0066","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.psychres.2020.112937_bib0067","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10803-006-0234-7","article-title":"Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Pandina","year":"2007","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0068","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41386-018-0039-3","article-title":"A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures","volume":"43","author":"Politte","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2020.112937_bib0069","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10803-009-0878-1","article-title":"Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007\u20132008","volume":"40","author":"Rosenberg","year":"2010","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0070","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","article-title":"Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity","volume":"62","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0071","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1176\/appi.ajp.2015.15010055","article-title":"Extended-release guanfacine for hyperactivity in children with autism spectrum disorder","volume":"172","author":"Scahill","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0072","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/1362361313497537","article-title":"Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program","volume":"18","author":"Schubert","year":"2014","journal-title":"Autism"},{"key":"10.1016\/j.psychres.2020.112937_bib0073","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/da.20410","article-title":"Efficacy of cognitive-behavioral and pharmacological treatments for children with social anxiety","volume":"25","author":"Segool","year":"2008","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psychres.2020.112937_bib0074","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/cap.2015.0189","article-title":"Effect of atomoxetine treatment on reading and phonological skills in children with dyslexia or attention-deficit\/hyperactivity disorder and comorbid dyslexia in a randomized, placebo-controlled trial","volume":"27","author":"Shaywitz","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0075","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","article-title":"Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs","volume":"41","author":"Snyder","year":"2002","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2020.112937_bib0076","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1542\/peds.2012-3774","article-title":"Psychotropic medication use and polypharmacy in children with autism spectrum disorders","volume":"132","author":"Spencer","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.psychres.2020.112937_bib0077","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/DBP.0000000000000189","article-title":"How valid is the checklist for autism spectrum disorder when a child has apraxia of speech?","volume":"36","author":"Tierney","year":"2015","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.psychres.2020.112937_bib0078","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","volume":"359","author":"Walkup","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2020.112937_bib0079","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/15374416.2011.581617","article-title":"A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication na\u00efve children with ADHD","volume":"40","author":"Waschbusch","year":"2011","journal-title":"J. Clin. Child Adolesc. Psychol."},{"key":"10.1016\/j.psychres.2020.112937_bib0080","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.sleep.2017.02.006","article-title":"The association between disruptive mood dysregulation disorder symptoms and sleep problems in children with and without ADHD","volume":"37","author":"Waxmonsky","year":"2017","journal-title":"Sleep Med."},{"key":"10.1016\/j.psychres.2020.112937_bib0081","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/cap.2008.065","article-title":"The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit\/hyperactivity disorder and severe mood dysregulation","volume":"18","author":"Waxmonsky","year":"2008","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.112937_bib0082","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/1087054713500144","article-title":"Morning and evening effects of guanfacine extended release adjunctive to psychostimulants in pediatric ADHD: results from a phase III multicenter trial","volume":"21","author":"Wilens","year":"2017","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.psychres.2020.112937_bib0083","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJM199402033300501","article-title":"Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children","volume":"330","author":"Wolraich","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2020.112937_bib0084","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.283.8.1025","article-title":"Trends in the prescribing of psychotropic medications to preschoolers","volume":"283","author":"Zito","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2020.112937_bib0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archpedi.157.1.17","article-title":"Psychotropic practice patterns for youth: a 10-year perspective","volume":"157","author":"Zito","year":"2003","journal-title":"Arch. Pediatrics Adolesc. Med."},{"key":"10.1016\/j.psychres.2020.112937_bib0086","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archpedi.153.12.1257","article-title":"Psychotherapeutic medication patterns for youths with attention-deficit\/hyperactivity disorder","volume":"153","author":"Zito","year":"1999","journal-title":"Arch. Pediatrics Adolesc. Med."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119321444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119321444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:38:40Z","timestamp":1759037920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178119321444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":86,"alternative-id":["S0165178119321444"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2020.112937","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptom scores and medication treatment patterns in children with ADHD versus autism","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2020.112937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112937"}}